This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date 12 July 2023 CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Approves Cash Dividend for the Year 2022 CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Proposes Final Cash Dividend for the Year 2022 CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong completed the acquisition of a 99.22% stake in Ningxia EPPEN Biotech Co.,ltd from a group of sellers. CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date: 08 July 2022 CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Approves Cash Dividend for 2021 CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Proposes Final Cash Dividend for the Year 2021 CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong signed a Letter of Intent to acquire a 99.22% stake in Ningxia EPPEN Biotech Co.,ltd from a group of sellers for approximately CNY 5.376 billion. CI
Guangzhou Longzhijie Technology Co., Ltd. announced that it expects to receive CNY 90 million in funding from Beijing Chieftain Control Engineering Technology Co., Ltd. CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Tranche Update on Beijing Chieftain Control Engineering Technology Co., Ltd.'s Equity Buyback Plan announced on February 8, 2021. CI
Beijing Chieftain Control Engineering Technology Co., Ltd.'s Equity Buyback plan announced on February 8, 2021, has expired with 2,051,800 shares, representing 0.76% for CNY 21.05 million. CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Tranche Update on Beijing Chieftain Control Engineering Technology Co., Ltd.'s Equity Buyback Plan announced on February 8, 2021. CI
Beijing Chieftain Control Engineering Technology Co., Ltd. Announces 2020 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on July 6, 2021 CI
Beijing Chieftain Control Engineering Technology : Buys Back More Shares in May MT
Chart Beijing Chieftain Control Engineering Technology Co., Ltd.
More charts
Beijing Chieftain Control Engineering Technology Co., Ltd. is a China-based company primarily engaged in the provision of medical and biological industrial automation control system integrated solutions. The Company focuses on automation control applications in the production process of pharmaceutical and biotechnology products, and provides automation control system products and integrated solutions to large and medium sized pharmaceutical, biotechnology companies, based on independent research and development of core technologies and independent produced key equipment and components. Its main products include four series: Fermentation and Synthesis, Purification, Product Preparation, as well as Auxiliary Process.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
16.33
Average target price
-
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300430 Stock
  4. News Beijing Chieftain Control Engineering Technology Co., Ltd.
  5. Beijing Chieftain Control Engineering Technology : Buys Back More Shares in May